Key facts
- It has raised $53.9M; the latest was Later Stage VC ($24.0M) in Dec 2025.
- Notable investors include Tech Incubator Program for Startup, Matter (Consulting Services (B2B)), Mirae Asset Capital, Premier Partners, KB Securities — 23 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 23 names
- ·Watchlist + deal alerts for AITRICS
- ·The full record, as it builds
Funding rounds
No funding rounds for AITRICS are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About AITRICS
Operator of a clinical decision support platform intended to improve patient outcomes by using health data to its full potential. The company's platform utilizes machine learning technologies with evidence-based expert analysis to provide real-time clinical insights, capable of transforming reactive disease care to care that is predictive, preventive, personalized, and participatory, enabling clinicians to enhance treatment and expand knowledge.
- Sector
- Healthcare
- HQ
- Seoul, South Korea
- Founded
- 2016
- Employees
- 180
- Website
- aitrics.com/
- Ownership
- Privately Held (backing)
AITRICS doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AITRICS shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AITRICS in its N-PORT filings yet. We sweep new filings monthly.